Effects of nonesterified fatty acids on glucose metabolism after glucose ingestion

Diabetes

Volumn 46, Issue 10, 1997, Pages 1586-1593

  Kruszynska, Yolanta T ^a,b   Mulford, Mim I ^a   Yu, Joseph G ^a   Armstrong, Debra A ^a   Olefsky, Jerrold M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; HYPOTHESIS; INSULIN RESPONSE; LIPID COMPOSITION; MALE; NORMAL HUMAN; OXIDATION; POSTPRANDIAL STATE; PRIORITY JOURNAL;

EID: 0030771331     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.46.10.1586     Document Type: Article

References (63)

1. Meylan M, Henny C, Temler E, Jequier E, Felber JP: Metabolic factors in the insulin resistance in human obesity. Metabolism 36:256-261, 1987
2. Gomez F, Jequier E, Chabot V, Buber V, Felber JP: Carbohydrate and lipid oxidation in normal human subjects: its influence on glucose tolerance and insulin response to glucose. Metabolism 21:381-391, 1972
3. Rousselle J, Buckert A, Pahud P, Jequier E, Felber JP: Relationship between glucose oxidation and glucose tolerance in man. Metabolism 32:866-870, 1982
4. Boden G, Ray TK, Smith RH, Owen OE: Carbohydrate oxidation and storage in obese non-insulin-dependent diabetic patients: effects of improving glycaemic control. Diabetes 32:982-987, 1983
5. Golay A, Felber JP, Meyer HU, Curchod B, Maeder E, Jequier E: Study on lipid metabolism in obesity diabetes. Metabolism 33:111-116, 1984
6. Roust LR, Jensen MD: Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 42:1567-1573, 1993
7. Piatti PM, Monti LD, Davis SN, Conti M, Brown MD, Pozza G, Alberti KGMM: Effects of an acute decrease in non-esterifled fatty acid levels on muscle glucose utilization and forearm indirect calorimetry in lean NTDDM patients. Diabetologia 39:103-112, 1996
8. Kruszynska YT: The role of fatty acid metabolism in the hypertriglyceridaemia and insulin resistance of type 2 (non-insulin dependent) diabetes. Diabetes Annu 9:107-139, 1995
9. Randle PJ, Garland PB, Hales CN, Newsholme EA: The glucose fatty acid cycle: its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet i:785-789, 1963
10. Randle PJ, Newsholme EA, Garland PB: Regulation of glucose uptake by muscle: effects of fatty acids, ketone bodies, pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles. Biochem J 93:652-665, 1964
11. Rennie MJ, Holloszy JO: Inhibition of glucose uptake and glycogenolysis by availability of oleate in well-oxygenated perfused skeletal muscle. Biochem J 168:161-170, 1977
12. Roden M, Price TB, Perseghin G, Petersen KF, Rothman DL, Cline GW, Shulman GI: Mechanism of free fatty-acid induced insulin resistance in humans. J Clin Invest 97:2859-2865, 1996
13. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
14. Lee KU, Lee HK, Koh CS, Min HK: Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 31:285-290, 1988
15. Boden G, Chen X, Ruiz J, White JV, Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446, 1994
16. Bonadonna RC, Zych K, Boni C, Ferrannini E, DeFronzo RA: Time dependence of the interaction between lipid and glucose in humans. Am J Physiol 257:E49-E56, 1989
17. Ferrannini E, Bjorkman O, Reichard GA, Pilo A, Olsson M, Wahren J, DeFronzo RA: The disposal of an oral glucose load in healthy subjects: a quantitative study. Diabetes 34:580-588, 1985
18. Katz LD, Glickman MG, Rapopart S, Ferrannini E, DeFronzo RA: Splanchnic and peripheral glucose disposal of oral glucose in man. Diabetes 32:675-679, 1983
19. Groop LC, Bonadonna RC, Shank M, Petrides AS, DeFronzo RA: Role of free fatty acids and insulin in determining free fatty acid and lipid oxidation in man. J Clin Invest 87:83-89, 1991
20. Yki-Jarvinen H, Puhakainen I, Saloranta C, Groop L, Taskinen MR: Demonstration of a novel feedback mechanism between FFA oxidation from intracellular and intravascular sources. Am J Physiol 260:E680-E689, 1991
21. Walker M, Fulcher GR, Sum CF, Orskov H, Alberti KGMM: Effect of glycaemia and non-esterified fatty acids on forearm glucose uptake in normal humans. Am J Physiol 261-E304-E311, 1991
22. Rebrin K, Steil GM, Getty L, Bergman RN: Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045, 1995
23. Rebrin K, Steil GM, Mittelman S, Bergman RN: Causal linkage between insulin regulation of lipolysis and liver glucose output. J Clin Invest 98:741-749, 1996
24. Sindelar DK, Chu CA, Rohlie M, Neal DW, Swift LL, Cherrington AD: The role of fatty acids in mediating the effects of peripheral insulin on hepatic glucose production in the conscious dog. Diabetes 46:187-196, 1997
25. Lewis GF, Zinman B, Groenewoud Y, Vranic M, Giacca A: Hepatic glucose production is regulated by direct and extrahepatic effects of insulin in humans. Diabetes 45:454-462, 1996
26. Prager R, Wallace P, Olefsky JM: Direct and indirect effects of insulin to inhibit hepatic glucose output in obese subjects. Diabetes 36:607-611, 1987
27. Jenkins AB, Storlien LH, Chisholm DJ, Kraegen EW: Effects of non-esterified fatty acid availability on tissue-specific glucose utilization in rats in vivo. J Clin Invest 82:293-299, 1988
28. Kruszynska YT, McCormack JG, McIntyre N: Effect of glycogen stores and non-esterified fatty acid availability on insulin-stimulated glucose metabolism and tissue pyruvate dehydrogenase activity in the rat Diabetologia 34:205-211, 1991
29. Patel T, Barren L, Olson M: The stimulation of hepatic gluconeogenesis by acetoacetate precursors. J Biol Chem 259:7525-7531, 1984
30. Saloranta C, Franssila-Kallunki M, Ekstrand A, Taskinen M-R, Groop L: Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 34:409-415, 1991
31. Fulcher GR, Walker M, Catalano C, Agius L, Alberti KGMM: Metabolic effects of suppression of non-esterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41:1400-1408, 1992
32. Dillion RS: Importance of the hematocrit in interpretation of blood sugar. Diabetes 14:672-674, 1965
33. Thorburn AW, Gumbiner B, Flynn T, Henry RR: Substrate oxidation errors during combined indirect calorimetry-hyperinsulinemic glucose clamp studies. Metabolism 40:391-398, 1991
34. Ferrannini E: The theoretical bases of indirect calorimetry: a review. Metabolism 37:287-301, 1988
35. Jequier E, Felber, J-P: Indirect calorimetry. In: Techniques for Metabolic Investigation in Man. Alberti KGMM, Home PD, Taylor R, Eds. (Bailliere's clinics in endocrinology and metabolism: Vol 1, Part 1.) London, Bailliere-Tindall, 1987, p. 911-935
36. Frayn, KN: Calculation of substrate oxidation rate in vivo from gaseous exchange. J Appl Physiol 55:628-634, 1983
37. Somogyi MJ: Determination of blood sugar. J Biol Chem 160:69-73, 1945
38. Bloom B: The simultaneous determination of [C14] and [H3] in the terminal groups of glucose. Anal Biochem 3:85-87, 1967
39. Reichard GA, Moury NF, Hochella NJ, Patterson AL, Weinhouse S. Quantitative estimation of the Cori cycle in the human. J Biol Chem 238:495-501, 1963
40. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody bound peptide hormones in radioimmunoassays. J Clin Endocrinol Metab 33:732-738, 1971
41. Faber OK, Binder C, Markussen J, Heding LG, Naithani VK, Kazuga H, Blix P, Horwitz DL, Rubenstein AH: Characterization of seven C-peptide antisera. Diabetes 27 (Suppl. 1):170-177, 1978
42. Steele R: Influences of glucose loading and of injected insulin on hepatic glucose output. Ann N Y Acad Sci 82:420-430, 1959
43. Wolfe RR: Tracers in Metabolic Research: Radioisotope/Mass Spectrometry Methods. New York, Liss, 1984, p. 81-101
44. Chiasson JL, Liljenquist JE, Lacy WW, Jennings AS, Cherrington AD: Gluconeogenesis: methodological approaches in vivo. Fed Proc 36:229-235, 1977
45. Nurjhan N, Consoli A, Gerich J: Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. J Clin Invest 89:169-175, 1992
46. Dagher FJ, Lyons JH, Finlayson DC, Shamsai J, Moore FD: Blood volume measurement: a critical study. Adv Surg 1:69-109, 1965
47. Boden G, Chen X: Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J Clin Invest 96:1261-1268, 1995
48. Mitrakou A, Kelley D, Veneman T, Jenssen T, Pangburn T, Reilly J, Gerich J: Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. Diabetes 39:1381-1390, 1990
49. Kruszynska YT, Olefsky JM: Cellular and molecular mechanisms of non-insulin dependent diabetes mellitus. J Invest Med 44:413-428, 1996
50. Gottesman I, Mandarino L, Gerich J: Use of glucose uptake and glucose clearance for the evaluation of insulin action in vivo. Diabetes 33:184-192, 1984
51. Hennes MMI, Dua A, Kissebah AH: Effects of free fatty acids and glucose on splanchnic insulin dynamics. Diabetes 46:57-62, 1997
52. Warnotte C, Gilon P, Nenquin M, Henquin J-C: Mechanisms of the stimulation of insulin release by saturated fatty acids: a study of palmitate effects in mouse β cells. Diabetes 43:703-711, 1994
53. Stein DT, Esser V, Stevenson BE, Lane KE, Whiteside JH, Daniels MB, Chen S, McGarry JD: Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat. J Clin Invest 97:2728-2735, 1996
54. Bjontorp P, Sjostrom L: Carbohydrate metabolism in man. Speculations and some quantitative considerations. Metabolism 27 (Suppl. 2):1853-1863, 1978
55. Jackson RA, Hamling JB, Sim BM, Hawa MI, Blix PM, Nabarro JDN: Peripheral lactate and oxygen metabolism in man: the influence of oral glucose loading. Metabolism 36:144-150, 1987
56. Hagstrom E, Arner P, Ungerstedt U, Bolinder J: Subcutaneous adipose tissue: a source of lactate production after glucose ingestion in humans. Am J Physiol 258:E888-E893, 1990
57. Marin P, Rebuffe-Scrive M, Smith U, Bjorntorp P: Glucose uptake in human adipose tissue. Metabolism 36:1154-1160, 1987
58. Kelley D, Mitrakou A, Marsh H, Schwenk F, Benn J, Sonnenberg G, Arcangeli M, Aoki T, Sorensen J, Berger M, Sonksen P, Gerich J: Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest 81:1563-1571, 1988
59. Yki-Jarvinen H, Puhakainen I, Koivisto VA: Effect of free fatty acids on glucose uptake and nonoxidative glycolysis across human forearm tissues in the basal state and during insulin stimulation. J Clin Endocrinol Metab 72:1268-1277, 1991
60. Kim JK, Wi JK, Youn JH: Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats. Diabetes 45:446-453, 1996
61. Kruszynska YT, McCormack JG, McIntyre N: Effects of non-esterified fatty acid availability on insulin stimulated glucose utilisation and tissue pyruvate denydrogenase activity in the rat. Diabetologia 33:396-402, 1990
62. Youn JH, Bergman RN: Conversion of oral glucose to lactate in dogs: primary site and relative contribution to blood lactate. Diabetes 40:738-747, 1991
63. Radziuk J, Inculet R: The effects of ingested and intravenous glucose on forearm uptake of glucose and gluconeogenic substrate in normal man. Diabetes 32:977-981, 1983